Q-linea awarded a contract position with Premier, Inc.

Effective September 1, 2026, the new agreement allows the over 4,000 Premier member hospitals, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the ASTar® instrument and the ASTar BC G- kit.

“This is an important commercial milestone for Q-linea in the U.S.,” said Ethan Suttles, Director of Sales – US & Americas at Q-linea. “By simplifying procurement and contracting, we expect to materially shorten our sales cycles and support faster adoption of ASTar across member institutions.”

ASTar is Q-linea’s rapid antimicrobial susceptibility testing system, designed to provide actionable results significantly faster than conventional methods. By enabling earlier optimization of antibiotic therapy, ASTar supports improved patient outcomes, reduced antibiotic misuse, and more efficient hospital workflows.

Premier is a leading technology-driven healthcare improvement company. Playing a critical role in the rapidly evolving healthcare industry, Premier unites providers, suppliers and payers to make healthcare better with national scale, smarter with actionable intelligence and faster with novel technologies. Headquartered in Charlotte, N.C., Premier offers integrated data and analytics, collaboratives, supply chain solutions, advisory services and other solutions in service of our mission to improve the health of communities.